首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1542476

全球心臟再同步治療設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Cardiac Resynchronization Therapy Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球心臟再同步治療設備市場需求預計將從 2023 年的 50.7 億美元增至 2032 年的近 80.9 億美元，2024-2032 年研究期間複合年成長率為 5.32%。

心臟再同步治療設備是一種小型電子設備，透過手術植入皮下以幫助兩個心室一起收縮。該裝置使用電脈衝來使心臟以正常速度跳動。它們也稱為起搏器。 CRT 設備透過提高心臟效率和增加血流量來幫助心臟病患者。心律調節器觸發心室以更協調的方式收縮，從而改善心臟的血液泵送。

市場動態

全球心血管疾病負擔的增加正在推動心臟再同步治療設備的成長。心血管疾病是全球第一大死因，估計每年奪走 1,790 萬人的生命。作為改善症狀的治療措施，正在取得許多進展：即開發心外膜和心內膜引線、開發旋入式引線、改進引線材料和尖端形狀、類固醇洗脫引線以及延長電池壽命生活。預期壽命和健康保險的成長預計將加速治療過程，從而增加對 CRT 設備的需求。然而，與 CRT 設備植入相關的高成本手術預計將限制市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心臟再同步治療設備市場的各個細分市場進行了包容性評估。心臟再同步治療設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心臟再同步治療設備市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

CRT-去顫器
CRT心律調節器

按最終用途

醫院
心臟中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟再同步治療設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟再同步治療設備市場的主要參與者包括美敦力（Medtronic）、雅培（Abbott）、波士頓科學公司（Boston Scientific Corporation）、Biotronik SE & Co. KG、微創科學公司（MicroPort Scientific Corporation）、Livanova Plc。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：心臟再同步治療設備公司的競爭格局

心臟再同步治療設備市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Medtronic

公司概況
公司收入
產品
最新動態

Abbott

公司概況
公司收入
產品
最新動態

Boston Scientific Corporation

公司概況
公司收入
產品
最新動態

Biotronik SE & Co. KG

公司概況
公司收入
產品
最新動態

MicroPort Scientific Corporation

公司概況
公司收入
產品
最新動態

Livanova Plc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212560

The global demand for Cardiac Resynchronization Therapy Devices Market is presumed to reach the market size of nearly USD 8.09 Billion by 2032 from USD 5.07 Billion in 2023 with a CAGR of 5.32% under the study period 2024-2032.

Cardiac resynchronization therapy devices are a small electronic device that is surgically implanted under the skin to help both ventricles contract together. This device uses electrical pulses to punctuate the heart to beat at a normal rate. They are also called pacemakers. CRT devices help heart patient by improving the heart's efficiency and increasing blood flow. The pacemaker triggers ventricles to contract in a more coordinated way, which improves the pumping of blood out of the heart.

MARKET DYNAMICS

Rising global burden of cardiovascular diseases is driving the growth of cardiac resynchronization therapy devices. Cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives each year. Many advances are being made as a therapeutic measure to improve the symptoms: namely, the development of the epicardial and endocardial leads, development of a screw-in lead, improvements in lead material and tip shape, a steroid-eluting lead, and prolong battery life. The growing life expectancy and health insurance are anticipated to accelerate the treatment procedure, thus the demand for CRT devices. However, high-cost surgery associated with CRT devices implant is projected to restrain the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Resynchronization Therapy Devices. The growth and trends of Cardiac Resynchronization Therapy Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Resynchronization Therapy Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

CRT-Defibrillator
CRT-Pacemaker

By End-use

Hospital
Cardiac Center
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Resynchronization Therapy Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Resynchronization Therapy Devices market include Medtronic, Abbott, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Livanova Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CARDIAC RESYNCHRONIZATION THERAPY DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. CRT-Defibrillator Historic and Forecast Sales By Regions
5.4. CRT-Pacemaker Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospital Historic and Forecast Sales By Regions
6.4. Cardiac Center Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CARDIAC RESYNCHRONIZATION THERAPY DEVICES COMPANIES

8.1. Cardiac Resynchronization Therapy Devices Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Abbott
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boston Scientific Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Biotronik SE & Co. KG
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. MicroPort Scientific Corporation
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Livanova Plc
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
CRT-Defibrillator Market Sales By Geography (USD MN)
CRT-Pacemaker Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospital Market Sales By Geography (USD MN)
Cardiac Center Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Cardiac Resynchronization Therapy Devices Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cardiac Resynchronization Therapy Devices Report
Market Research Process
Market Research Methodology
Global Cardiac Resynchronization Therapy Devices Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
CRT-Defibrillator Market Sales By Geography (USD MN)
CRT-Pacemaker Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospital Market Sales By Geography (USD MN)
Cardiac Center Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis